| Financial Year |
March 31 2023 |
| Monetary Funds |
719,854,720.90 |
| Held-for-trading Financial Assets |
60,174,000.00 |
| Notes Receivable |
22,962,964.43 |
| Accounts Receivable |
169,767,719.03 |
| Advances to Suppliers |
114,229,960.37 |
| Other Receivables |
1,855,365.98 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
353,519,550.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
14,170,482.47 |
| Total Current Assets |
1,542,374,451.61 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,003,249.56 |
| Investment Properties |
-- |
| Fixed Assetes |
601,914,003.53 |
| Under-construction Projects |
79,047,363.58 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
27,269,891.16 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
2,051,663.87 |
| Deferred Income Tax Assets |
2,674,586.55 |
| Other Non-Current Assets |
3,522,440.71 |
| Sub-Total of Non-Current Assets |
717,483,198.96 |
| Total Assets |
2,259,857,650.57 |
| Short-Term Loans |
246,302,339.05 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
120,201,771.04 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,311,415.43 |
| Taxes Payable |
873,530.20 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
15,053,902.89 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
61,332.88 |
| Other Current Liabilities |
6,358,600.43 |
| Sub-Total of Current Liabilities |
399,790,955.77 |
| Long-term Loans |
-- |
| Bonds Payable |
302,566,223.80 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
137,709.51 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
305,165,599.97 |
| Total Liabilities |
704,956,555.74 |
| Paid-In Capital(Or Share Stock) |
489,604,568.00 |
| Capital Surplus |
467,172,202.62 |
| Surplus Reserve |
76,460,317.76 |
| LESS:Treasury Stock |
8,551,468.80 |
| Undistributed Profits |
481,559,723.32 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,554,901,094.83 |
| Owner's Equity（Stockholder's Equity） |
1,554,901,094.83 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,259,857,650.57 |
